Documents

List of IAC members.

The World Bank appreciates the opportunity to comment on the GAVI Health System Strengthening (HSS) Evaluation conducted by HLSP. The document contains much useful information but may require some fine-tuning regarding its key findings/recommendations.

This paper provides the Secretariat’s response to HLSP’s “GAVI Health Systems Strengthening Support Evaluation 2009” of 8 October 2009.

In August 2008, GAVI awarded JSI Research & Training Institute, Inc. (JSI) a contract to work with its partner organisation in Sweden, InDevelop-Institute of Public Management to jointly implement the GAVI HSS tracking study. The tracking study was designed to provide real-time evidence regarding the technical, managerial, and policy processes for the successful implementation of GAVI HSS grants in a set of six countries.

The selection process for Independent Assessment Committee (IAC) members is administered by the GAVI Alliance Secretariat, in its role as AMC Secretariat. Evaluation of candidates is conducted by a selection panel composed of five international leaders on global health issues.

The evaluation's main recommendations are expected to contribute to inform the GAVI Board decision in 2010 about whether or not to increase the funding available to the GAVI Health System Strengthening (HSS) support window; to improve current and future implementation of GAVI HSS; to enhance the quality of the GAVI HSS evaluation planned for 2012.

A case study on the multi-sector effort to build a financing mechanism, the AMC, as an incentive to facilitate vaccine development.

The evaluation objectives included: the experience at country level with GAVI HSS, the main strengths and areas of improvement of GAVI HSS at the country level; how has GAVI HSS been supported at regional and global levels; what has been the value-added of funding HSS through GAVI; and what needs to be done on all levels for a more in-depth evaluation of imapact of GAVI HSS in 2012.

The process of the Pneumococcal AMC involves donors, IBRD, UNICEF, suppliers, the AMC Independent Assessment Committee (IAC), developing countries and participating manufacturers.

This version 0.1 is issued in accordance with the AVI Forecasting Standard Operating Procedure that foresees the possibility for intermediate updates between official versions when changes in demand exceed predefined thresholds. 

Frequently asked questions about the Pneumococcal AMC.

Frequently asked questions about the Pneumococcal AMC.

Master definitions schedule relating to the AMC for pneumococcal vaccines.

Pneumococcal vaccine strategic demand forecast corresponding to AMC required supply.

Health Systems Funding Platform Frequently Asked Questions (FAQ) 1. What is the Health Systems Funding Platform? The Health Systems Funding Platform (the Platform) is a way for development partners, including the GAVI Alliance, the Global Fund and the World Bank, with facilitation from the World Health Organization (WH

The World Bank, The GAVI Alliance and the AMC Donor Committee sought stakeholder input on the planning and design of the pilot AMC through expert groups, consultations, meetings and roundtables. The aim was to incorporate into the design of the AMC the recommendations of economists, global health experts, medical practitioners and scientists from developing and industrialized countries as well as manufacturers and civil society organizations. 

The Oxford Declaration is a call to action on the prevention of cervical cancer in Africa; agreed upon by members on 27 March 2009.

The charter and bylaws of the Independent Assessment Committee (IAC).

The process of the Pneumococcal AMC involves donors, IBRD, UNICEF, suppliers, the AMC Independent Assessment Committee (IAC), developing countries and participating manufacturers.

Секретариат ГАВИ, 26 февраля 2009 года 1 Примечание по Руководству1 Проводимые по инициативе ГАВИ оценки управления финансами Февраль 2009 год I. Задача Пояснительной записки В нижеследующем документе представлена важная информация о проводимой ГАВИ оценке управления финансами (ОУФ) для стран, имеющих право на получени

This document provides GAVI‐eligible countries and their development partners with important information on the GAVI Financial Management Assessment (FMA). As of 1 January 2009, the FMA will will be required before a country can receive cash support for NEW Health Systems Strengthening (HSS) and Immunisation Services Support (ISS) programmes; this includes proposals approved in November of 2008.

GAVI s strategic approach GAVI is developing a comprehensive vaccine investment strategy in 2008 to determine which vaccines it will offer to countries in the future, ensuring the best use of resources and maximum immunisation impact.

This report presents the findings of an evaluation commissioned by the GAVI Alliance to analyze the sustainability of its Injection Safety (INS) support. In 2002, GAVI started providing INS support to national immunization programs to introduce or increase the use of Auto-Disable (AD) syringes. The support came in two forms: 1) in-kind, in the form of AD syringes and safety boxes, and 2) in cash, for those countries that already had a secure, multi-year source of AD syringes and safety boxes, but proposed to use INS support for other injection safety activities.